Preliminary data with affinity crosslinking and flow cytometry indicate that proteins of the SNARE-cascade regulating the insulin excretion from beta-cells could be associated with the IC2 specific targeted epitope.
Preliminary data with affinity crosslinking and flow cytometry indicate that proteins of the SNARE-cascade regulating the insulin excretion from beta-cells could be associated with the IC2 specific targeted epitope.
ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.
The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.